Edinburgh PhD: Protein Modifications and Malaria-Related Host–Parasite Adhesion

Edinburgh PhD: Protein Modifications and Malaria-Related Host–Parasite Adhesion

Research question and applicant decision

This four-year Edinburgh doctorate connects protein-modification evidence, experimental interpretation and computational/structural analysis in malaria-related host–parasite biology. It is not a proven clinical intervention. The 2027 delegated directory lists project 200203 with Professor J. Alexandra Rowe and Senior Lecturer Nisha Philip. EastBio accepts international applicants. Successful international EastBio awardees receive a waiver of the international tuition top-up, and EastBio excludes visa/IHS costs. EDC international eligibility, allocation, tuition top-up and visa/IHS coverage are unknown; the 2027 stipend also needs confirmation. The project is attractive for comparing biological evidence with predictions, but the experimental/computational balance and daily supervision are not fixed publicly. Current official recruitment route; International award boundary

Research Question and Doctoral Work

The advertised question concerns how post-translational modifications relate to host–parasite adhesion interactions in malaria research. Recruitment describes observations and a hypothesis requiring investigation, not a demonstrated universal mechanism. Disease relevance is the motivation; it does not establish a treatment, patient diagnostic rule or approved intervention.

At applicant level, the doctoral work includes interpreting functional evidence from host and parasite contexts, checking consistency between evidence classes, and comparing bioinformatic predictions and structural visualisation, with PyMOL explicitly named. Both experiment and computation are advertised; this should not be presented as a purely computational position. A predicted annotation, a structural image and a functional observation do not establish the same claim. The difficult intellectual task is understanding the limits of each evidence class and whether conclusions generalise to another biological context.

The advert does not make prior PyMOL mastery a formal admissions requirement, or publish the student’s equipment allocation, data volume, collaborator contracts or final thesis specification. Ask what proportion of effort is analysis versus other approved responsibilities, which training is provided and what bounded independent contribution is expected. Material access and institutional governance are matters for the research team, not assumptions from a tool list.

The field’s value lies in interpreting molecular and quantitative evidence together; its central limitation is the gap between prediction, association and causal or clinical conclusions. The recent papers below show relevant team activity across evidence scales, but are not direct validation of this exact proposed modification/adhesion project.

School, Programme and Field Context

The degree-awarding institution is University of Edinburgh, United Kingdom, and the academic home is School of Biological Sciences. The delegated directory places this project in Institute of Immunology and Infection Research. University institutes and centres can overlap with supervisors’ affiliations; they do not create a joint or double degree. Confirm the physical host and day-to-day group. Official current recruitment route

The specified registration is Biological Sciences (with Internship) PhD, 48 months full-time, starting 1 October 2027, at the University of Edinburgh. The first year is probationary; a thesis committee supports progress, and students must pass an annual review to progress. First-year reports are due at 10 weeks and 10 months, with an oral presentation at the latter review. The programme describes a year-two poster, a year-three research presentation, and a final thesis of up to 100,000 words defended in a viva. Cohort training spans methods, research, professional and thematic skills. The advert includes a three-month placement; ordinary PIPS is typically up to three months, or up to six with approval. The project is not marked CASE and names no company; host, timing and expenses remain to be agreed. Exact programme and registration; Training framework

The School’s REF 2021 Biological Sciences account reports 94% world-leading/internationally excellent research and 100% world-leading environment, with a UK-top-five subject claim. This is a dated national subject assessment, not a 2027 global ranking or a score for the individual lab. Research training is not a clinical qualification. Subject evidence and assessment year

Supervisors, Recent Primary Research and Resources

Institutional records identify J. Alexandra (Alex) Rowe as Professor and Personal Chair in Molecular Medicine. Nisha Philip is Senior Lecturer, not the older Lecturer label used elsewhere. Their confirmed roles and complementary malaria/protein-evidence interests should be preserved without inventing the formal lead/daily split. Philip’s official group page describes a Duke pharmacology doctorate and establishment of her Edinburgh group in 2017, with current postdoctoral and doctoral members. Rowe current role; Philip current role; Group/training context

The three distinct recent original studies below include named project supervisors: two include Rowe and one includes Philip. Evidence reviewed was at institutional abstract/bibliographic level; the 2025 record also included author contributions, and publication-header checks were bibliographic only. No full paper was read; the entries retain each study's specific evidence and access limits.

Travassos and colleagues: clinical-context observations

Mark A Travassos; Paul Han; Drissa Coulibaly; Emily M Stucke; Albert E Zhou; Biraj Shrestha; Rie Nakajima; Aarti Jain; Omid Taghavian; Algis Jasinskas; Jonathan G Lawton; Matthew B Laurens; Amadou Niangaly; Andrew Pike; Amed Ouattara; Andrea A Berry; Matthew Adams; Shannon Takala-Harrison; Bourema Kouriba; Abdoulaye K Kone; J Alexandra Rowe; Ogobara K Doumbo; Kirsten E Lyke; Philip L Felgner; Christopher V Plowe; Mahamadou A Thera. Distinct Plasmodium falciparum Erythrocyte Membrane Protein 1 Domain Cassette-Associated Antibody Gaps Specific to Cerebral Malaria and Severe Malarial Anemia. The Journal of Infectious Diseases 234(3): 462–474. Online 2026-05-27; issue 2026-09-15. DOI: 10.1093/infdis/jiag256.

Rowe is 21st of 26 authors; Mark A. Travassos is the corresponding author. The publisher citation assigns the paper to the 15 September 2026 issue, whereas the institutional record still says ahead of print.

The observational cohort comparison cannot clearly distinguish prior exposure from protective immunity. It provides clinical-context research experience, not causal proof, individual prognosis or validation of this proposed project. Evidence reviewed: institutional abstract/bibliography and publisher citation/header; no full-text reading. Institutional record; Current publisher citation

Bailey and colleagues: host-background limits

Rachel D. Bailey; Jonathan G. Lawton; Amadou Niangaly; Emily M. Stucke; Jason A. Bailey; Andrea A. Berry; Amed Ouattara; Drissa Coulibaly; Kirsten E. Lyke; Matthew B. Laurens; Albert E. Zhou; Jozelyn Pablo; Algis Jasinskas; Rie Nakajima; Matthew Adams; Shannon Takala-Harrison; Bourema Kouriba; Abdoulaye K. Kone; Aldiouma Guindo; J. Alexandra Rowe; Dapa A. Diallo; Ogobara K. Doumbo; Philip L. Felgner; Christopher V. Plowe; Mahamadou A. Thera; Mark A. Travassos. Children with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigens. Journal of Infection 89(4): 106257. Online 2024-08-30; issue 2024-10. DOI: 10.1016/j.jinf.2024.106257.

Rowe is 20th of 26 authors; this check did not independently establish the corresponding author.

The observational study shows that interpretation of serological differences depends on host background and exposure. It does not establish universal protection or individual risk. No molecular targets or adhesion-modification strategy are reproduced. Evidence reviewed: institutional bibliographic record only; publisher access failed, so the full paper was unavailable. 2024 observational study

Pazicky and colleagues: protein-association evidence

Samuel Pazicky; Seth Tjia; Guilherme B Farias; Nick Piwon; Nisha Philip; Radoslaw M. Sobota; Andrew P. Waters; Tim-Wolf Gilberger; Zbynek Bozdech. MAP-X reveals distinct protein complex dynamics across Plasmodium falciparum blood stages. Nature Microbiology 10(12): 3229–3244. Online 2025-11-28; issue 2025-12. DOI: 10.1038/s41564-025-02173-7.

Philip is fifth of nine authors. The contribution statement credits her with formal analysis, investigation, funding acquisition, methodology, visualisation and review/editing; supervision is attributed to Waters, Gilberger and Bozdech, and the institutional record marks Bozdech as corresponding author.

It supports collaborative quantitative protein-evidence expertise, not Philip’s sole leadership. Predicted associations are not individually validated functions or proof of the proposed adhesion hypothesis. Evidence reviewed: institutional metadata and contribution statement; publisher access failed, so the full methods and supplementary data were unavailable. 2025 primary protein-evidence study

Philip’s generic opportunities page, dated 2 September 2024, still says no open position and anticipates Autumn 2026 advertising. The exact 2027 delegated listing is newer evidence; the old generic text is not a basis for declaring the project closed. Rowe’s profile lists a research collaboration to 2032, whereas Philip’s listed MRC award ends March 2027; neither constitutes this student’s four-year personal award. Confirm actual continuity, capacity and analytical support. School shared facilities do not guarantee personal access. Temporal context; Shared resources

Funding and International Costs

The project call advertises a four-year fully funded competition for either an EASTBIO BBSRC Doctoral Landscape Award or an Edinburgh Doctoral College Award. It describes a monthly stipend at the UKRI standard rate, tuition cover and support for project costs; no separate EDC application is required. This is an opportunity to compete, not an award already made to an individual. EastBio accepts international applicants, and no more than 30% of annual EastBio-network awards may go to international students. This is a network allocation cap, not a UKRI-wide rule or an individual applicant’s probability; whether EDC is subject to the cap remains unconfirmed. Successful international EastBio awardees have the international tuition top-up waived, and EastBio rules exclude visa/IHS costs. EDC international eligibility, allocation, tuition top-up and visa/IHS coverage are unknown. Confirm the named award and 2027 stipend in the offer. EASTBIO international rules; School funding routes

The School describes EDC support as tuition plus a four-year stipend and project grant £5,000 in years 1–3 and £1,000 in year 4: £16,000 total research support, not extra living income. UKRI's confirmed 2026/27 minimum is £21,805 stipend and £5,238 Home-fee contribution; the 2027/28 rate is not yet given there. EDC grant scope; Confirmed current UKRI reference

The university estimates 2026/27 living costs £18,504/year or £1,542/month, calculated March 2026: accommodation/utilities £978, food/shopping £248, mobile £12, social/leisure/wellbeing £246, bus (age 22+) £58 monthly. Accommodation/utilities illustrations range £752–£1,249/month; the lower private figure is based on a room-share calculation, not a private whole-flat quote or guaranteed place. These are dated planning references; the 2027 award amount, housing choice and excluded arrival/travel costs must be checked separately. No disposable-income balance is calculated. Current budget methodology

At October 2026 rates, the Student visa application fee is £558, and student IHS is £776/year with partial-year charging rules. If chargeable permission were 4.5 years, the IHS example would be £3,492, or £4,050 with the application fee; actual CAS/permission duration and future rates determine the bill.

The outside-London visa maintenance figure £1,171/month for up to 9 months (£10,539) is a regulatory evidence threshold, not a full-year Edinburgh budget. Sponsorship/CAS and Chinese differential-evidence arrangements require individual checking. Travel, deposits and cash before the first stipend remain separate. Visa fee; IHS rules; Maintenance evidence

Background, Language and Application

The exact advert does not impose a separate project-specific degree classification, prior instrument/software mastery or an extra English threshold. Relevant preparation includes molecular/parasitology evidence, quantitative interpretation, bioinformatics and structural visualisation, but these are analyst-suggested preparation areas. PyMOL is a named research tool, not an advertised compulsory pre-entry credential. The programme normally expects a relevant UK 2:1 or international equivalent, some research experience and good understanding of the proposed field. Relevant industrial experience may partly meet the research-experience expectation; non-standard backgrounds are assessed case by case. EastBio does not generally require a master’s. Chinese degree equivalence is assessed individually. Mentioned methods are not automatically pre-entry requirements. Actual degree requirements

For 2027 entry, the programme specifies IELTS 6.5 overall/6.0 each, without One Skill Retake. TOEFL taken before 21 January 2026 uses 92 overall/23 each; from that date the new scale requires 4.5 overall/4.5 each, without MyBest aggregation. Check validity and alternative qualifications on the programme page. Non-English academic records require originals plus official translations. An application may precede the English test, but final offer conditions still apply. Student-visa holders must register full-time and live within commuting distance; individual ATAS/CAS conditions must be checked. 2027 language criteria; International study conditions IELTS and TOEFL must be no more than two years old on the first day of the programme’s starting month. An English-taught degree is an alternative only under the University’s approved country/institution and age rules; it is not automatically accepted because teaching was in English.

Only one EastBio project across all hosts may be selected. Contact the named supervisors, prepare the 2027 EastBio form, transcripts, anonymous EDI-survey response ID, and two references using the official form. Referees can be academic/professional but cannot be the project supervisors. Extra documents such as CVs are disregarded in the formal process; an informal supervisor contact is distinct. The programme charges no application fee. Mandatory application materials; Document rules

Submit through Euclid: Biological Sciences with Internship, 1 October 2027, enter title/supervisors/funding source, and upload the EastBio form to the Research Proposal section. The upload label does not itself request an additional experimental proposal. The listed application deadline is midday Monday 16 November 2026, with references accepted up to two weeks later; no timezone is specified. Central guidance requests references by 16 November and says incomplete references disadvantage shortlisting. Aim for all documents by the main deadline and obtain written host confirmation before relying on an extension. Euclid can email referees a link, but they still need the official template. Application route and main deadline; Reference timing and exceptions

The project instructions keep applications under consideration until 22 February 2027, request missing information through Euclid, and reserve amendment/withdrawal of scholarships. Check the portal and email. Central dates are 18 January nominations, 22 February interview invitations, week beginning 8 March interviews, week beginning 22 March decisions, with 1 October entry. These are selection stages, not an interview or award promise. Current selection timetable

Career directions

The transferable value is rigorous quantitative interpretation, critical comparison and collaborative biological research. The National Careers Service gives a broad UK biochemist occupation range of £28,000 starter–£53,000 experienced. It is a general labour-market reference, not this project’s placement record or a promised salary. Career evidence and its scope

The group page gives named alumni examples: a 2025 PhD graduate working for the NHS, a former EastBio student now a senior scientist at xGenomes in Cambridge, and a former student now a Glasgow postdoc. These are concrete individual outcomes, not a complete destination survey, placement rate or clinical qualification. Ask about actual careers support and recent full-cohort outcomes.

Next Actions and Questions by Stage

Before applying: choose the single project; confirm degree equivalence, English evidence and the host’s reference deadline. The 2027 delegated directory lists the opportunity, but current acceptance still needs confirmation. The saved materials do not confirm the contents of the university project page.

At interview: clarify the independent thesis question and experimental/computational division; how are predictions and observations evaluated without overclaiming validation? Confirm Rowe/Philip lead and daily roles, training, analytical capacity, governance responsibilities and ordinary placement. Ask how current research funding and supervisory arrangements support the full 2027–2031 period, without assuming older generic vacancies or separate grants determine this award.

Before accepting: obtain the named award, 2027 stipend, research/placement expenses, funded period and completion arrangements in writing. For EastBio, confirm the documented international tuition top-up waiver and uncovered visa/IHS costs; for EDC, obtain written international eligibility, tuition top-up and visa/IHS terms. Check the supervision/committee agreement, individual CAS/ATAS conditions, housing and arrival cash. Neither shared facilities nor a supervisor’s publication/grant record guarantees personal access, current supervisory capacity or career outcomes.

Evidence and Sources

The papers' bibliographic dates, evidence levels and access limitations are stated above. The delegated listing does not establish current acceptance or individual award and resource terms; the saved materials do not confirm the contents of the university project page.

• EASTBIO current official application and delegated project directory
• EASTBIO current eligibility and overseas fee waiver
• EASTBIO selection and timeline
• EASTBIO training structure
• Edinburgh Biological Sciences REF 2021 subject context
• Biological Sciences with Internship current 2027 programme
• SBS2027 current EASTBIO and EDC funding
• Edinburgh postgraduate living costs 2026/27
• UKRI current stipend and fee minima
• UK Student visa current application fee
• UK student health surcharge
• UK outside-London maintenance evidence
• National Careers Service biological scientist careers
• J Alexandra Rowe current institutional role
• Nisha Philip current institutional role and primary record
• Philip group roles, training and named alumni outcomes
• Travassos et al. 2026 malaria-cohort primary study
• Bailey et al. 2024 observational serology primary study
• Pazicky et al. 2025 protein-association primary study
• Philip group opportunity-page temporal scope
• School shared analytical and microscopy resources
• University project page